Free Answer to Counterclaim - District Court of Delaware - Delaware

Case 1 :06-cv-00741-SLR Document 37 Filed 04/ 1 1/2007 Page 1 of 4 E
IN THE UNITED STATES DISTRICT COURT Q
FOR THE DISTRICT OF DELAWARE
CELGENE CORPORATION, NOVARTIS )
PHARMACEUTICALS CORPORATION ) Z
and NOVARTIS PHARMA AG, )
, )
Plaintiff, ) Civil Action N0. 06-741-SLR
)
V. ) n
ABRIKA PHARMACEUTICALS, INC. g
and ABRIKA Pi·IARi\/IACEUTICALS, )
LLLP, )
Defendant. g
PLAINTIFFS' REPLY TO THE COUNTERCLAIMS OF DEFENDANTS ABRIKA
PHARMACEUTICALS, INC. AND ABRIKA PHARMACEUTICAL, LLLP
Plaintiffs Ceigene Corporation, Novartis Pharmaceuticals Corporation and Novartis
Pharma AG (collectively, "plaintiffs"), by their undersigned counsel, and in reply to the
counterclaims ("Counterclaims") of Defendants Abrika Pharmaceuticals, Inc. and Abrika
Pharmaceuticals, LLLP (collectively, "defendants"), state as follows:
1. Admitted
2. Admitted.
3. Admitted.
4. Admitted.
5. Admitted.
6. Plaintiffs reassert and incorporate their responses to paragraphs 1 through 5
above, as though fully set forth herein.
7. Admitted
8. Admitted.

Case 1:06-cv—00741-SLR Document 37 Filed O4/11/2007 Page 2 of 4 7
9. Admitted
10. Plaintiffs refer to the ’284 patents for what they state, and plaintiffs otherwise
deny any remaining allegation or allegations of paragraph 10 ofthe Connterclairns.
ll. Plaintiffs admit that plaintiffs maintain that defendants methylphenidate
hydrochloride extended-re1ease capsules 20 mg, 30 mg, and 40 mg ("Abrii Products") infringe the '284 patents and that the ’284 patents are valid. Plaintiffs also admit that
defendants deny that Abrikais Proposed Products infringe the 2284 patents and that the '284
patents are valid. The remaining allegations contained in paragraph ll of the Connterclaims are
the subject of plaintiffs pending motion to dismiss.
l2. Plaintiffs are without knowledge or information sufficient to form a belief as to
the truth of the allegations set forth in paragraph I2 of the Connterclaims and, therefore, deny
them. _
1 3 . Denied.
14. Denied.
i 15. The allegations contained in paragraph 15 of the Counterclaims are the subject of
plaintiffs pending motion to dismiss.
l6i Plaintiffs admit that actual and justiciable controversies exist between plaintiffs
and defendants regarding the infringement and validity of the *284 patents. The remaining
allegations contained in paragraph 16 of the Coanterclaims are the subject of plaintiffs pending
motion to dismiss.
17. Denied.
- 2 -

Case 1:06-cv—00741-SLR Document 37 Filed O4/11/2007 Page 3 of 4
PRAYER FOR RELIEF
Plaintiffs deny that defendants are entitled to any relief on the Counterclaims.
POTTER ANDERSON & CORROON LLP
or COUNSEL:
Anthony M. lnsogna By; ‘
L€>S11€1” sl- $81**11 Philip A. Rovner (#3215)
JONES DAY Hercules Plaza
12265 El Camino Real, Suite 200 p_{)_ BOX 95]
Sai] Di€g0» CA 92130 Wilmington, Delaware 19899
(858) 314-1209 (302) 984-6000
[email protected]
F. Dominic Cerrito
JONES DAY Attorneys for Plairztmt
222 East 41st Street
New York, NY 10017-6702
(212) 326—-3939
Attorneys for PlaintWCelgene Corporation
Robert L. Baechtold
Henry J. Renk
Nicholas N. Kallas (
FITZPATRICK, CELLA, HARPER &
SCINTO
30 Rockefeller Plaza
New York, NY 10112
(212) 218-2100
Attorneys for Piaintwis
Novartis Pharmaceuticals Corporation and
Novartis Pharma AG
Dated: April 11, 2007
788614
- 3 -

_ Case 1:06-cv—00741-SLR Document 37 Filed O4/11/2007 Page 4 of 4 ‘
IN THE UNITED STATES DISTRICT COURT I
FOR THE DISTRICT OF DELAWARE .
CERTIFICATE OF SERVICE
I, Philip A. Rovner, hereby certify that on April 1 1, 2007, the within document
was tiled with the Clerk of the Court using CM/ECF which will send notification of such
tiling(s) to the following; that the document was served on the following counsel as indicated;
and that the document is available for viewing and downloading from CM/ECF.
BY HAND DELIVERY AND E»MAIL
Andre G. Bouchard, Esq.
John M. Seaman, Esq.
Bouchard Margules & Friedlander, P.A. q
222 Delaware Avenue, Suite 1400
Wilmington, DE 19801
ahouchardg@bnit`-law.com
`;sea.ma11@bmf—iaw.com
I hereby certify that on April 11, 2007 I have sent the foregoing document by E—
mailto the following non—registered participants in the manner indicated:
Jonathan A. Harris, Esq. John Will Ongmazi, Esq.
Chad A. Landmon, Esq. Axinn, Veltrop & Harkrider LLP
Jo-Anne M. Kokoski, Esq. 1801 K Street
Axinn, Veltrop & Harkrider LLP Suite 411
90 State House Square Washington, DC 20006-1322
Hartford, CT 06}.03 j wo@,avhlaw. com
jah@,avhIaw.com;
cal@,avh1aw.com; ]`[email protected]
Philip A. Rovner (#32i 5)
Potter Anderson & Corroon LLP
Hercules Plaza
P. O. Box 951
Wilmington, DE 19899
(302) 984-6000
[email protected]
768868